ARTICLE
12 January 2017

Florida Board Of Medicine Hearing On Telemedicine And Medical Marijuana

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
The Florida Board of Medicine will hold a public hearing on February 3, 2017 to discuss its proposed amendment to Florida's telemedicine practice rules.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

The Florida Board of Medicine will hold a public hearing on February 3, 2017 to discuss its proposed amendment to Florida's telemedicine practice rules. The proposed amendment, published December 8, 2016, is intended to clarify that physicians may not order medical cannabis or low-THC cannabis via telemedicine.

The amendment would add a new Section (5) to the Standards for Telemedicine Practice under 64B8-9.0141, F.A.C. If the proposed amendment is finalized, the regulation would state as follows: "(5) Medical cannabis or low-THC cannabis, as defined by s. 381.986, F.S., may not be ordered by means of telemedicine."

Interested physicians and providers may want to attend the public hearing, both to learn more about the Board's position on medical marijuana and telemedicine, and to contribute their perspectives to inform the discussion. Some points of potentially-useful clarification to discuss at the hearing may include, for example:

  • Whether or not a physician may conduct a telemedicine-based exam to qualify a patient for Florida's compassionate use registry (and start the 90 day clock), assuming the physician subsequently conducts and in-person exam prior to ordering medical marijuana?
  • Whether or not a physician may use telemedicine-based exams for follow-up or interim consults with patients receiving medical marijuana?

Some states, like California, do not prohibit telemedicine-based examinations for medical marijuana, while others, like Colorado, require an in-person examination prior to recommending medical marijuana. Even in states that allow telemedicine-based examinations for medical marijuana, providers should keep in mind that the examination for the condition for which medical marijuana is being recommended must be an appropriate prior examination and meet the standard of care.

What's Next?

The Florida Board of Medicine public hearing will occur on February 3, 2017 at 8:00 a.m., at:

The Omni Orlando Resort at Championsgate
1500 Masters Boulevard
Championsgate, Florida 33896

We will continue to monitor the proposed rules for when the final version is published.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More